Compare CWD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWD | IMCC |
|---|---|---|
| Founded | 2009 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 10.4M |
| IPO Year | 2023 | N/A |
| Metric | CWD | IMCC |
|---|---|---|
| Price | $1.68 | $1.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 164.5K | ★ 208.3K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $24,657,000.00 | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | $26.80 | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $1.63 | $0.93 |
| 52 Week High | $48.00 | $7.12 |
| Indicator | CWD | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | 48.87 |
| Support Level | $1.69 | $1.54 |
| Resistance Level | $1.83 | $2.08 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 4.35 | 29.71 |
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.